Riskpilot← Back to searchSign inGet full accessCITY LEGESENTER AS
ASActiveOrg 915371310Nedre Storgate 6, 3015 DrammenGeneral medical practice activities · NACE 8621Est. 20156 employees
Revenue 2024
NOK 4,4M
-2% vs 2023
EBITDA margin
0.5%
-60% vs 2023
Equity ratio
28.8%
Financial strength
Net profit 2024
NOK 14K
-65% vs 2023
| Revenue | NOK 4,4M | -2% |
| EBITDA | NOK 24K | -60% |
| Net profit | NOK 14K | -65% |
| Total assets | NOK 501K | -15% |
| Equity | NOK 144K | +10% |
| Employees | 6 | — |
Legal name
CITY LEGESENTER AS
Org number
915371310
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
20. mai 2015
Share capital
NOK 50 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Legevirksomhet, samt alt hva hermed står i forbindelse.
Address
Nedre Storgate 6, 3015 Drammen
Phone
+4731003750
Email
post@citylegesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 535 | 3 993 | 4 180 | 4 487 | 4 400 |
| Staff expenses | −1 830 | −1 797 | −2 121 | −2 178 | −2 158 |
| EBITDA | −153 | 236 | −149 | 60 | 24 |
| Depreciation & amort. | −52 | −0 | −0 | −0 | −0 |
| EBIT | −206 | 236 | −149 | 60 | 24 |
| Net financials | −8 | −4 | −15 | −8 | −6 |
| Profit before tax | −213 | 232 | −164 | 52 | 18 |
| Tax | −47 | 53 | −33 | 13 | 4 |
| Net profit | −166 | 179 | −131 | 39 | 14 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 356 | 698 | 490 | 589 | 501 |
| Equity | 44 | 223 | 92 | 131 | 144 |
| Long-term debt | 14 | 33 | 0 | 13 | 17 |
| Short-term debt | 298 | 441 | 398 | 446 | 339 |
| Total debt | 312 | 474 | 398 | 458 | 356 |
EBITDA margin
0.5%
This company
15.8%
Market median
-97% vs market
20202024
Equity ratio
28.8%
This company
38.2%
Market median
-25% vs market
20202024
Return on equity
9.4%
This company
18.4%
Market median
-49% vs market
20202024
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20202024
Asset turnover
8.79×
This company
1.12×
Market median
+685% vs market
20202024
Debt / equity
2.47×
This company
0.62×
Market median
-298% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EW Chief Executive Officer | Chief Executive Officer | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CITY LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ellen Wang Ræstad | Chief Executive Officer | 0 companies |
| Sarah Giessing Kallevik Haagensen | Chairman | 0 companies |
| Frøydis Anne Brunvoll Sørensen | Board of Directors | 0 companies |